E-LIB Suche - Ergebnisse für: López‐Sendón Moreno, Jose L - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Substantia Nigra Echogenicity Predicts Response to Drug Wit..:

López‐Sendón Moreno, Jose L. ; Alonso‐Cánovas, Araceli ; Buisán Catevilla, Javier...
Movement Disorders Clinical Practice. 3 (2015) 3 - p. 268-274 , 2015

Link: https://doi.org/10.1002/..

2

Eye‐of‐the‐Tiger Sign with an Unexpected Pathological Diagn..:

Natera‐Villalba, Elena ; Martínez‐Castrillo, Juan Carlos ; López‐Sendón Moreno, José Luis...
Movement Disorders Clinical Practice. 9 (2021) 1 - p. 98-103 , 2021

Link: https://doi.org/10.1002/..

3

SURINPARK: Safinamide for Urinary Symptoms in Parkinson's D..:

Gómez-López, Ana ; Sánchez-Sánchez, Arantxa ; Natera-Villalba, Elena...
Brain Sciences. 11 (2021) 1 - p. 57 , 2021

Link: https://doi.org/10.3390/..

4

Novel mutations in the KCNJ10 gene associated to a distinct..:

Morin, Matias ; Forst, Anna-Lena ; Pérez-Torre, Paula...
neurogenetics. 21 (2020) 2 - p. 135-143 , 2020

Link: https://doi.org/10.1007/..

5

Transcranial sonography in atypical parkinsonism: How relia..:

Alonso-Canovas, Araceli ; Tembl Ferrairó, José Ignacio ; Martínez-Torres, Irene...
Parkinsonism & Related Disorders. 68 (2019) - p. 40-45 , 2019

Link: https://doi.org/10.1016/..

6

Quantification of the Light Subunit of Neurofilament Protei..:

Szejko, Natalia ; Picón, Carmen ; García-Caldentey, Juan...
PLoS Currents. , 2018

Link: https://doi.org/10.1371/..

7

Current Methods for the Treatment and Prevention of Drug-In..:

Estevez-Fraga, Carlos ; Zeun, Paul ; López-Sendón Moreno, Jose Luis
Drugs & Aging. 35 (2018) 11 - p. 959-971 , 2018

Link: https://doi.org/10.1007/..

8

Does normal substantia nigra echogenicity make a difference..:

Alonso-Canovas, Araceli ; Lopez-Sendon Moreno, Jose Luis ; Buisan, Javier...
Journal of Neurology. 265 (2018) 10 - p. 2363-2369 , 2018

Link: https://doi.org/10.1007/..

9

Incobotulinumtoxin A for Sialorrhea in Neurological Disorde..:

Martínez-Poles, Javier ; Nedkova-Hristova, Velina ; Escribano-Paredes, José Bernardo...
Toxins. 10 (2018) 6 - p. 217 , 2018

Link: https://doi.org/10.3390/..

10

Phenomenology and disease progression of chorea-acanthocyto..:

Estévez-Fraga, Carlos ; López-Sendón Moreno, Jose Luis ; Martínez-Castrillo, Juan Carlos...
Parkinsonism & Related Disorders. 49 (2018) - p. 17-21 , 2018

Link: https://doi.org/10.1016/..

11

Dyskinesia-hyperpyrexia syndrome under continuous dopaminer..:

Acebrón Sánchez-Herrera, Fernando ; García-Barragán, Nuria ; Estévez-Fraga, Carlos..
Parkinsonism & Related Disorders. 36 (2017) - p. 103-104 , 2017

Link: https://doi.org/10.1016/..

12

A double-blind, randomized, cross-over, placebo-controlled,..:

López-Sendón Moreno, Jose Luis ; García Caldentey, Juan ; Trigo Cubillo, Patricia...
Journal of Neurology. 263 (2016) 7 - p. 1390-1400 , 2016

Link: https://doi.org/10.1007/..

13

Substantia Nigra Echogenicity Predicts Response to Drug Wit..:

López‐Sendón Moreno, Jose L ; Alonso‐Cánovas, Araceli ; Buisán Catevilla, Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178591/. , 2015

Link: http://www.ncbi.nlm.nih...

14

A 5-year follow-up of deep brain stimulation in Huntington'..:

López-Sendón Moreno, Jose Luis ; García-Caldentey, Juan ; Regidor, Ignacio..
Parkinsonism & Related Disorders. 20 (2014) 2 - p. 260-261 , 2014

Link: https://doi.org/10.1016/..

15

Neuroleptic Malignant Syndrome Induced by Olanzapine in a P..:

Moreno, Jose Luis López-Sendón ; Palau Fayos, Jose María ; Díaz de Santiago, Alberto.
Journal of Huntington's Disease. 1 (2012) 1 - p. 31-32 , 2012

Link: https://doi.org/10.3233/..

1-15